ATE171179T1 - Positiv inotropische und lusitropische pyrrolochinolinonderivate - Google Patents

Positiv inotropische und lusitropische pyrrolochinolinonderivate

Info

Publication number
ATE171179T1
ATE171179T1 AT94918875T AT94918875T ATE171179T1 AT E171179 T1 ATE171179 T1 AT E171179T1 AT 94918875 T AT94918875 T AT 94918875T AT 94918875 T AT94918875 T AT 94918875T AT E171179 T1 ATE171179 T1 AT E171179T1
Authority
AT
Austria
Prior art keywords
pct
lusitropic
positive inotropic
pyrrolocinolinone
derivatives
Prior art date
Application number
AT94918875T
Other languages
English (en)
Inventor
Eddy Jean Edgard Freyne
Alfons Herman Marg Raeymaekers
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE171179T1 publication Critical patent/ATE171179T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT94918875T 1993-06-21 1994-06-15 Positiv inotropische und lusitropische pyrrolochinolinonderivate ATE171179T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93201771 1993-06-21

Publications (1)

Publication Number Publication Date
ATE171179T1 true ATE171179T1 (de) 1998-10-15

Family

ID=8213908

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94918875T ATE171179T1 (de) 1993-06-21 1994-06-15 Positiv inotropische und lusitropische pyrrolochinolinonderivate

Country Status (29)

Country Link
US (1) US5602134A (de)
EP (1) EP0707586B1 (de)
JP (1) JP2812804B2 (de)
KR (1) KR0181560B1 (de)
CN (1) CN1043765C (de)
AT (1) ATE171179T1 (de)
AU (1) AU679077B2 (de)
BG (1) BG62171B1 (de)
BR (1) BR9406899A (de)
CA (1) CA2163122C (de)
CZ (1) CZ284350B6 (de)
DE (1) DE69413398T2 (de)
FI (1) FI109124B (de)
HU (1) HU220670B1 (de)
IL (1) IL110055A (de)
LT (1) LT3447B (de)
LV (1) LV11545B (de)
MY (1) MY110751A (de)
NO (1) NO305366B1 (de)
OA (1) OA10202A (de)
PH (1) PH31308A (de)
PL (1) PL176783B1 (de)
RU (1) RU2129554C1 (de)
SG (1) SG49717A1 (de)
SI (1) SI9420041A (de)
SK (1) SK280400B6 (de)
TW (1) TW593317B (de)
WO (1) WO1995000512A1 (de)
ZA (1) ZA944382B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes
EP1434765B1 (de) * 2001-09-14 2009-12-02 High Point Pharmaceuticals, LLC Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
TWI498115B (zh) * 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
GB0808953D0 (en) * 2008-05-16 2008-06-25 Shire Llc substituted quinazolines
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
RU2457208C2 (ru) * 2009-07-06 2012-07-27 Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО "ПГФА Росздрава") 1H-ПИРРОЛО[3,4-b]ХИНОЛИН-3,9(2H,4H)-ДИОНЫ, ОБЛАДАЮЩИЕ ПРОТИВОТУБЕРКУЛЕЗНОЙ АКТИВНОСТЬЮ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
WO2024149378A1 (zh) * 2023-01-13 2024-07-18 上海超阳药业有限公司 喹啉酮化合物和萘啶酮化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775674A (en) 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
CN1030196C (zh) * 1989-07-07 1995-11-01 詹森药业有限公司 增强收缩力和舒张力的-二氢咪唑并喹唑啉酮衍生物的制备方法
NZ234186A (en) * 1989-07-07 1991-10-25 Janssen Pharmaceutica Nv Imidazo quinazolin-one derivatives and pharmaceutical compositions
US5220023A (en) * 1989-07-18 1993-06-15 Janssen Pharmaceutica N.V. Glycine derivatives
US4943573A (en) 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas

Also Published As

Publication number Publication date
AU7000894A (en) 1995-01-17
EP0707586B1 (de) 1998-09-16
NO955028D0 (no) 1995-12-12
WO1995000512A1 (en) 1995-01-05
HUT72090A (en) 1996-03-28
CA2163122C (en) 2005-06-14
FI956143A0 (fi) 1995-12-20
NO305366B1 (no) 1999-05-18
MY110751A (en) 1999-02-27
PH31308A (en) 1998-07-06
LV11545B (en) 1997-08-20
ZA944382B (en) 1995-12-20
HU220670B1 (hu) 2002-04-29
IL110055A0 (en) 1994-10-07
HU9501970D0 (en) 1995-09-28
PL176783B1 (pl) 1999-07-30
IL110055A (en) 1997-09-30
TW593317B (en) 2004-06-21
KR0181560B1 (ko) 1999-05-01
LT3447B (en) 1995-10-25
SK159695A3 (en) 1997-01-08
AU679077B2 (en) 1997-06-19
CN1043765C (zh) 1999-06-23
BG100209A (bg) 1996-07-31
LTIP1960A (en) 1995-01-31
NO955028L (no) 1995-12-12
DE69413398T2 (de) 1999-04-15
US5602134A (en) 1997-02-11
EP0707586A1 (de) 1996-04-24
CN1125945A (zh) 1996-07-03
DE69413398D1 (de) 1998-10-22
JPH09500108A (ja) 1997-01-07
RU2129554C1 (ru) 1999-04-27
FI956143A (fi) 1995-12-20
JP2812804B2 (ja) 1998-10-22
CA2163122A1 (en) 1995-01-05
CZ284350B6 (cs) 1998-10-14
FI109124B (fi) 2002-05-31
PL312252A1 (en) 1996-04-01
SG49717A1 (en) 1998-06-15
SI9420041A (en) 1996-08-31
CZ336695A3 (en) 1996-03-13
SK280400B6 (sk) 2000-01-18
BR9406899A (pt) 1996-04-09
OA10202A (en) 1996-12-18
LV11545A (lv) 1996-10-20
BG62171B1 (bg) 1999-04-30

Similar Documents

Publication Publication Date Title
TR200400238T4 (tr) ''Perindopril tert-bütilamin tuzunun alfa kristalin şekli''
TW274547B (de)
BR9407239A (pt) Azadioxacicloalquenos substituídos
DK0696281T3 (da) Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater
ATE125442T1 (de) Nagellacke.
DE69413398D1 (de) Positiv inotropische und lusitropische pyrrolochinolinonderivate
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
FI952458A0 (fi) Dimetyylibentsofuraanien ja dimetyylibentsopyraanien käyttö 5-HT3-antagonisteina
FI940106A0 (fi) Menetelmä sertraliinin valmistamiseksi
PL322872A1 (en) Novel triazolones - inhibitors of b apolipoprotein synthesis
DK0646110T3 (da) N-substituerede 3-azabicyclo(3.2.0) heptanderivater som neuroleptika
SE9202218D0 (sv) Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
TW339325B (en) Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same
ZA944317B (en) New phosphonosuccinic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing them
DK0625972T3 (da) Fremgangsmåde til fremstilling af 2-amino-7-nitrobenzothiazoler
YU41396A (sh) Novi n-etil-n-1-naftil acilamidi i postupak njihovog dobijanja